Flarer acquires a new representation: Synbias Pharma AG

Flarer expands its horizons into the field of Oncology products, Precursors and High Potency. Synbias Pharma GMP manufacturing processes ensure high quality products at competitive prices. In addition to producing and marketing the API, Synbias is able to provide a service of production of finished products. Flarer and Synbias look to the future and are committed to ensure the highest quality of products and services designed to meet the needs of all their Partners.